Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1).

Perez MC, Zager JS, Amatruda T, Conry R, Ariyan C, Desai A, Kirkwood JM, Treichel S, Cohan D, Raskin L.

Melanoma Manag. 2019 Jul 3;6(2):MMT19. doi: 10.2217/mmt-2019-0012.

2.

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.

Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV.

Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Review.

PMID:
31267972
3.

Comment on "Comparison of surgical margins for lentigo maligna versus melanoma in situ".

Navarrete-Dechent C, Aleissa S, Ariyan C, Busam KJ, Nehal KS.

J Am Acad Dermatol. 2019 Oct;81(4):e115-e116. doi: 10.1016/j.jaad.2019.05.104. Epub 2019 Jun 21. No abstract available.

PMID:
31233855
4.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT.

Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.

PMID:
30643254
5.

MelMART Trial: It's Now or Never.

Coit D, Ariyan C.

Ann Surg Oncol. 2018 Sep;25(9):2493-2495. doi: 10.1245/s10434-018-6573-8. Epub 2018 Jun 26. No abstract available.

PMID:
29946999
6.

Adipocyte-Derived Lipids Mediate Melanoma Progression via FATP Proteins.

Zhang M, Di Martino JS, Bowman RL, Campbell NR, Baksh SC, Simon-Vermot T, Kim IS, Haldeman P, Mondal C, Yong-Gonzales V, Abu-Akeel M, Merghoub T, Jones DR, Zhu XG, Arora A, Ariyan CE, Birsoy K, Wolchok JD, Panageas KS, Hollmann T, Bravo-Cordero JJ, White RM.

Cancer Discov. 2018 Aug;8(8):1006-1025. doi: 10.1158/2159-8290.CD-17-1371. Epub 2018 Jun 14.

7.

Primary and Metastatic Melanoma With NTRK Fusions.

Lezcano C, Shoushtari AN, Ariyan C, Hollmann TJ, Busam KJ.

Am J Surg Pathol. 2018 Aug;42(8):1052-1058. doi: 10.1097/PAS.0000000000001070.

8.

Adjuvant Therapy in the Treatment of Melanoma.

Bello DM, Ariyan CE.

Ann Surg Oncol. 2018 Jul;25(7):1807-1813. doi: 10.1245/s10434-018-6376-y. Epub 2018 Feb 21. No abstract available.

PMID:
29468608
9.

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade.

Ariyan CE, Brady MS, Siegelbaum RH, Hu J, Bello DM, Rand J, Fisher C, Lefkowitz RA, Panageas KS, Pulitzer M, Vignali M, Emerson R, Tipton C, Robins H, Merghoub T, Yuan J, Jungbluth A, Blando J, Sharma P, Rudensky AY, Wolchok JD, Allison JP.

Cancer Immunol Res. 2018 Feb;6(2):189-200. doi: 10.1158/2326-6066.CIR-17-0356. Epub 2018 Jan 16.

10.

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation.

Momtaz P, Harding JJ, Ariyan C, Coit DG, Merghoub T, Gasmi B, You D, Viale A, Panageas KS, Samoila A, Postow MA, Wolchok JD, Chapman PB.

Oncotarget. 2017 Sep 16;8(62):105000-105010. doi: 10.18632/oncotarget.21072. eCollection 2017 Dec 1.

11.

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH.

Ann Surg Oncol. 2018 Feb;25(2):356-377. doi: 10.1245/s10434-017-6267-7. Epub 2017 Dec 13.

PMID:
29236202
12.

Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.

Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH.

J Clin Oncol. 2018 Feb 1;36(4):399-413. doi: 10.1200/JCO.2017.75.7724. Epub 2017 Dec 12.

PMID:
29232171
13.

Transected thin melanoma: Implications for sentinel lymph node staging.

Herbert G, Karakousis GC, Bartlett EK, Zaheer S, Graham D, Czerniecki BJ, Fraker DL, Ariyan C, Coit DG, Brady MS.

J Surg Oncol. 2018 Mar;117(4):567-571. doi: 10.1002/jso.24930. Epub 2017 Nov 30.

14.

An Update on Randomized Clinical Trials in Melanoma.

Karakousis G, Ariyan C.

Surg Oncol Clin N Am. 2017 Oct;26(4):559-586. doi: 10.1016/j.soc.2017.05.002. Review.

PMID:
28923220
15.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

16.

Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma.

Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, Sivaprakasam K, Johnson DB, Crandall H, Busam KJ, Zismann V, Deluca V, Lee J, Sekulic A, Ariyan CE, Sosman J, Trent J.

Genome Res. 2017 Apr;27(4):524-532. doi: 10.1101/gr.213348.116.

17.

Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment.

Cassidy MR, Wolchok RE, Zheng J, Panageas KS, Wolchok JD, Coit D, Postow MA, Ariyan C.

EBioMedicine. 2017 Apr;18:56-61. doi: 10.1016/j.ebiom.2017.03.029. Epub 2017 Mar 24.

18.

Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.

Davis JL, Langan RC, Panageas KS, Zheng J, Postow MA, Brady MS, Ariyan C, Coit DG.

Ann Surg Oncol. 2017 Jul;24(7):1989-1996. doi: 10.1245/s10434-017-5836-0. Epub 2017 Mar 16.

19.

Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Grotz TE, Allred JB, Suman VJ, Brady MS, Tyler D, Wayne JD, Nelson H.

Ann Surg. 2017 Jan;265(1):192-196. doi: 10.1097/SLA.0000000000001670.

20.

Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedure.

Zendejas B, Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Tyler D, Brady MS, Farley DR.

Surg Endosc. 2017 Aug;31(8):3313-3319. doi: 10.1007/s00464-016-5364-1. Epub 2016 Dec 7.

21.

Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.

Lee AY, Droppelmann N, Panageas KS, Zhou Q, Ariyan CE, Brady MS, Chapman PB, Coit DG.

Ann Surg Oncol. 2017 Apr;24(4):939-946. doi: 10.1245/s10434-016-5642-0. Epub 2016 Nov 1.

22.

Decreased length of stay and earlier oral feeding associated with standardized postoperative clinical care for total gastrectomies at a cancer center.

Selby LV, Rifkin MB, Yoon SS, Ariyan CE, Strong VE.

Surgery. 2016 Sep;160(3):607-12. doi: 10.1016/j.surg.2016.04.036. Epub 2016 Jun 14.

23.

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.

Kuk D, Shoushtari AN, Barker CA, Panageas KS, Munhoz RR, Momtaz P, Ariyan CE, Brady MS, Coit DG, Bogatch K, Callahan MK, Wolchok JD, Carvajal RD, Postow MA.

Oncologist. 2016 Jul;21(7):848-54. doi: 10.1634/theoncologist.2015-0522. Epub 2016 Jun 10.

24.

Complete lymph node dissection in melanoma.

Ariyan C.

Lancet Oncol. 2016 Jun;17(6):688-689. doi: 10.1016/S1470-2045(16)30071-7. Epub 2016 May 5. No abstract available.

PMID:
27161538
25.

Training High-Volume Melanoma Surgeons to Perform a Novel Minimally Invasive Inguinal Lymphadenectomy: Report of a Prospective Multi-Institutional Trial.

Jakub JW, Terando AM, Sarnaik A, Ariyan CE, Faries MB, Zani S Jr, Neuman HB, Wasif N, Farma JM, Averbook BJ, Bilimoria KY, Allred JB, Suman VJ, Grotz TE, Zendejas B, Wayne JD, Tyler DS.

J Am Coll Surg. 2016 Mar;222(3):253-60. doi: 10.1016/j.jamcollsurg.2015.11.010. Epub 2015 Nov 25.

26.

Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.

Wiesner T, Lee W, Obenauf AC, Ran L, Murali R, Zhang QF, Wong EW, Hu W, Scott SN, Shah RH, Landa I, Button J, Lailler N, Sboner A, Gao D, Murphy DA, Cao Z, Shukla S, Hollmann TJ, Wang L, Borsu L, Merghoub T, Schwartz GK, Postow MA, Ariyan CE, Fagin JA, Zheng D, Ladanyi M, Busam KJ, Berger MF, Chen Y, Chi P.

Nature. 2015 Oct 15;526(7573):453-7. doi: 10.1038/nature15258. Epub 2015 Oct 7.

27.

Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review.

Johnson DB, Peng C, Abramson RG, Ye F, Zhao S, Wolchok JD, Sosman JA, Carvajal RD, Ariyan CE.

Oncologist. 2015 Jun;20(6):648-52. doi: 10.1634/theoncologist.2014-0468. Epub 2015 May 11.

28.

Update on immunotherapy in melanoma.

Green J, Ariyan C.

Surg Oncol Clin N Am. 2015 Apr;24(2):337-46. doi: 10.1016/j.soc.2014.12.010. Epub 2015 Jan 22. Review.

PMID:
25769716
29.

International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.

Melstrom LG, Taylor E, Kuk D, Frankel TL, Panageas K, Haydu L, Sabel MS, Thompson JF, Ariyan C, Coit DG, Brady MS.

Ann Surg Oncol. 2014 Dec;21(13):4324-9. doi: 10.1245/s10434-014-3845-9. Epub 2014 Jun 25.

PMID:
24962937
30.

CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.

Gill K, Ariyan C, Wang X, Brady MS, Pulitzer M.

J Surg Oncol. 2014 Sep;110(3):258-64. doi: 10.1002/jso.23636. Epub 2014 May 30.

PMID:
24891295
31.

Predicting the development of brain metastases in patients with local/regional melanoma.

Frankel TL, Bamboat ZM, Ariyan C, Coit D, Sabel MS, Brady MS.

J Surg Oncol. 2014 Jun;109(8):770-4. doi: 10.1002/jso.23574. Epub 2014 Feb 20.

32.

Observation after a positive sentinel lymph node biopsy in patients with melanoma.

Bamboat ZM, Konstantinidis IT, Kuk D, Ariyan CE, Brady MS, Coit DG.

Ann Surg Oncol. 2014 Sep;21(9):3117-23. doi: 10.1245/s10434-014-3758-7. Epub 2014 May 16.

PMID:
24833100
33.

The GIST of targeted therapy for malignant melanoma.

Bello DM, Dematteo RP, Ariyan CE.

Ann Surg Oncol. 2014 Jun;21(6):2059-67. doi: 10.1245/s10434-013-3373-z. Epub 2014 Feb 15. Review.

34.

Paradoxical activation of T cells via augmented ERK signaling mediated by a RAF inhibitor.

Callahan MK, Masters G, Pratilas CA, Ariyan C, Katz J, Kitano S, Russell V, Gordon RA, Vyas S, Yuan J, Gupta A, Wigginton JM, Rosen N, Merghoub T, Jure-Kunkel M, Wolchok JD.

Cancer Immunol Res. 2014 Jan;2(1):70-9. doi: 10.1158/2326-6066.CIR-13-0160.

35.

Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.

Steinman J, Ariyan C, Rafferty B, Brady MS.

J Surg Oncol. 2014 Apr;109(5):405-9. doi: 10.1002/jso.23519. Epub 2013 Dec 7.

PMID:
24318953
36.

Melanoma mutagenesis and aberrant cell signaling.

Bello DM, Ariyan CE, Carvajal RD.

Cancer Control. 2013 Oct;20(4):261-81. Review.

PMID:
24077403
37.

The delicate balance of melanoma immunotherapy.

Gyorki DE, Callahan M, Wolchok JD, Ariyan CE.

Clin Transl Immunology. 2013 Aug 9;2(8):e5. doi: 10.1038/cti.2013.5. eCollection 2013 Aug. Review.

38.

Prognosis of acral melanoma: a series of 281 patients.

Bello DM, Chou JF, Panageas KS, Brady MS, Coit DG, Carvajal RD, Ariyan CE.

Ann Surg Oncol. 2013 Oct;20(11):3618-25. doi: 10.1245/s10434-013-3089-0. Epub 2013 Jul 10.

PMID:
23838913
39.

Nivolumab plus ipilimumab in advanced melanoma.

Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, Lowy I, Inzunza HD, Feely W, Horak CE, Hong Q, Korman AJ, Wigginton JM, Gupta A, Sznol M.

N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2. Erratum in: N Engl J Med. 2018 Nov 29;379(22):2185.

40.

Immunological insights from patients undergoing surgery on ipilimumab for metastatic melanoma.

Gyorki DE, Yuan J, Mu Z, Zaidi B, Pulitzer M, Busam K, Brady MS, Coit DG, Allison JP, Wolchok JD, Ariyan CE.

Ann Surg Oncol. 2013 Sep;20(9):3106-11. doi: 10.1245/s10434-013-2999-1. Epub 2013 May 17.

41.

Locoregional lymphadenectomy in the surgical management of anorectal melanoma.

Perez DR, Trakarnsanga A, Shia J, Nash GM, Temple LK, Paty PB, Guillem JG, Garcia-Aguilar J, Bello D, Ariyan C, Carvajal RD, Weiser MR.

Ann Surg Oncol. 2013 Jul;20(7):2339-44. doi: 10.1245/s10434-012-2812-6. Epub 2013 Jan 18.

42.

Anal versus rectal melanoma: does site of origin predict outcome?

Bello DM, Smyth E, Perez D, Khan S, Temple LK, Ariyan CE, Weiser MR, Carvajal RD.

Dis Colon Rectum. 2013 Feb;56(2):150-7. doi: 10.1097/DCR.0b013e31827901dd.

43.

Prognostic significance of drainage to pelvic nodes at sentinel lymph node mapping in patients with extremity melanoma.

Karakousis GC, Pandit-Taskar N, Hsu M, Panageas K, Atherton S, Ariyan C, Brady MS.

Melanoma Res. 2013 Feb;23(1):40-6. doi: 10.1097/CMR.0b013e32835d5062.

PMID:
23250048
44.

Factors associated with inconsistent sun protection in first-degree relatives of melanoma survivors.

Shuk E, Burkhalter JE, Baguer CF, Holland SM, Pinkhasik A, Brady MS, Coit DG, Ariyan CE, Hay JL.

Qual Health Res. 2012 Jul;22(7):934-45. doi: 10.1177/1049732312443426.

45.

Controversies in the management of regional nodes in melanoma.

Plitas G, Ariyan CE.

J Natl Compr Canc Netw. 2012 Mar;10(3):414-21. Review.

PMID:
22393199
46.

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.

Balachandran VP, Cavnar MJ, Zeng S, Bamboat ZM, Ocuin LM, Obaid H, Sorenson EC, Popow R, Ariyan C, Rossi F, Besmer P, Guo T, Antonescu CR, Taguchi T, Yuan J, Wolchok JD, Allison JP, DeMatteo RP.

Nat Med. 2011 Aug 28;17(9):1094-100. doi: 10.1038/nm.2438.

47.

Desmoplastic melanoma in African American patients.

Busam KJ, Ariyan C, Coit DC.

Arch Dermatol. 2010 Jul;146(7):796-7. doi: 10.1001/archdermatol.2010.149. No abstract available.

PMID:
20644048
48.

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.

Yuan J, Page DB, Ku GY, Li Y, Mu Z, Ariyan C, Gallardo HF, Roman RA, Heine AI, Terzulli SL, Ritter E, Gnjatic S, Ritter G, Jungbluth AA, Allison JP, Old LJ, Wolchok JD.

Cancer Immun. 2010 Jan 7;10:1. Erratum in: Cancer Immun. 2010 Feb 24;10:5. Ritter, Erika [added].

49.

Outcome of patients with a positive sentinel lymph node who do not undergo completion lymphadenectomy.

Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG.

Ann Surg Oncol. 2010 Feb;17(2):514-20. doi: 10.1245/s10434-009-0836-3.

50.

Randomized clinical trials in melanoma.

Kingham TP, Karakousis G, Ariyan C.

Surg Oncol Clin N Am. 2010 Jan;19(1):13-31. doi: 10.1016/j.soc.2009.09.008. Review.

PMID:
19914558

Supplemental Content

Loading ...
Support Center